Effects of pharmacological stressors on c-fos and CRF mRNA in mouse brain: Relationship to alcohol seeking

Neuroscience Letters

Volumn 444, Issue 3, 2008, Pages 254-258

  Funk, Douglas ^a   Li, Zhaoxia ^a   Coen, Kathy ^a   Lê, Anh Dzung ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alcohol; c Fos; Corticotropin releasing factor; In situ hybridization; Reinstatement; Stress

Indexed keywords

ALCOHOL; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; PROTEIN C FOS; YOHIMBINE;

ALCOHOL CONSUMPTION; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN REGION; CELL ACTIVATION; CINGULATE GYRUS; CONTROLLED STUDY; FRONTAL CORTEX; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MOUSE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ALCOHOL-RELATED DISORDERS; ANIMALS; BRAIN; CARBOLINES; CORTICOTROPIN-RELEASING HORMONE; DRUG INVERSE AGONISM; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, GABA-A; RNA, MESSENGER; SPECIES SPECIFICITY; YOHIMBINE;

EID: 52049105389     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.08.043     Document Type: Article

References (50)

1. Asan E., Yilmazer-Hanke D.M., Eliava M., Hantsch M., Lesch K.P., and Schmitt A. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131 (2005) 953-967
2. Bain M.J., Dwyer S.M., and Rusak B. Restraint stress affects hippocampal cell proliferation differently in rats and mice. Neurosci. Lett. 368 (2004) 7-10
3. Baldwin H.A., Johnston A.L., and File S.E. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur. J. Pharmacol. 159 (1989) 211-215
4. Belknap J.K., Crabbe J.C., and Young E.R. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl.) 112 (1993) 503-510
5. Brodkin E.S., Carlezon Jr. W.A., Haile C.N., Kosten T.A., Heninger G.R., and Nestler E.J. Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents: initial studies in Lewis and Fischer 344 rats and in A/J and C57BL/6J mice. Brain Res. 805 (1998) 55
6. Calandreau L., Jaffard R., and Desmedt A. Dissociated roles for the lateral and medial septum in elemental and contextual fear conditioning. Learn. Mem. 14 (2007) 422-429
7. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol. Biochem. Behav. 32 (1989) 777-785
8. Cullinan W.E., Herman J.P., Battaglia D.F., Akil H., and Watson S.J. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 64 (1995) 477-505
9. Dole V.P., Ho A., Gentry R.T., and Chin A. Toward an analogue of alcoholism in mice: analysis of nongenetic variance in consumption of alcohol. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 827
10. Drago J., Gerfen C.R., Westphal H., and Steiner H. D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 74 (1996) 813-823
11. File S.E. Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behav. Brain Res. 21 (1986) 189-194
12. File S.E., Pellow S., and Braestrup C. Effects of the beta-carboline, FG 7142, in the social interaction test of anxiety and the holeboard: correlations between behaviour and plasma concentrations. Pharmacol. Biochem. Behav. 22 (1985) 941-944
13. Funk D., Harding S., Juzytsch W., and Le A.D. Effects of unconditioned and conditioned social defeat on alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl.) 183 (2005) 341-349
14. Funk D., Li Z., and Le A.D. Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 138 (2006) 235-243
15. Funk D., Li Z., Shaham Y., and Le A.D. Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain. Neuroscience 122 (2003) 1-4
16. GeneDetect, In situ hybridization using GeneDetect oligonucleotide probes, GeneDetect, Auckland, 2001.
17. Haapalinna A., Viitamaa T., MacDonald E., Savola J.M., Tuomisto L., Virtanen R., and Heinonen E. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn Schmiedebergs Arch. Pharmacol. 356 (1997) 570-582
18. Herman J.P., Schafer K.H., Sladek C.D., Day R., Young E.A., Akil H., and Watson S.J. Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons. Brain Res. 501 (1989) 235-246
19. Holmes A., and Rodgers R.J. Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Eur. J. Pharmacol. 459 (2003) 221-230
20. Hsu D.T., Chen F.L., Takahashi L.K., and Kalin N.H. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res. 788 (1998) 305-310
21. Imaki T., Katsumata H., Konishi S.I., Kasagi Y., and Minami S. Corticotropin-releasing factor type-1 receptor mRNA is not induced in mouse hypothalamus by either stress or osmotic stimulation. J. Neuroendocrinol. 15 (2003) 916-924
22. Kovacs K.J. c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem. Int. 33 (1998) 287-297
23. Le A., and Shaham Y. Neurobiology of relapse to alcohol in rats. Pharmacol. Ther. 94 (2002) 137-156
24. Le A.D., Harding S., Juzytsch W., Fletcher P.J., and Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci. 22 (2002) 7844-7849
25. Le A.D., Harding S., Juzytsch W., Funk D., and Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl.) 179 (2005) 366-373
26. Le A.D., Harding S., Juzytsch W., Watchus J., Shalev U., and Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl.) 150 (2000) 317-324
27. Le A.D., Quan B., Juzytsch W., Fletcher P.J., Joharchi N., and Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology 135 (1998) 169
28. Makino S., Shibasaki T., Yamauchi N., Nishioka T., Mimoto T., Wakabayashi I., Gold P.W., and Hashimoto K. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res. 850 (1999) 136-143
29. Marinelli P.W., Funk D., Juzytsch W., Harding S., Rice K.C., Shaham Y., and Lê A.D. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl.) 195 (2007) 345-355
30. Martin-Fardon R., Ciccocioppo R., Massi M., and Weiss F. Nociceptin prevents stress-induced ethanol but not cocaine-seeking behavior in rats. Neuroreport 11 (2000) 1939-1943
31. Matthews D.B., Bhave S.V., Belknap J.K., Brittingham C., Chesler E.J., Hitzemann R.J., Hoffmann P.L., Lu L., McWeeney S., Miles M.F., Tabakoff B., and Williams R.W. Complex genetics of interactions of alcohol and CNS function and behavior. Alcohol Clin. Exp. Res. 29 (2005) 1706-1719
32. Matthews D.B., Morrow L.A., O'Buckley T., Flanigan T.J., Berry R.B., Cook M.N., Mittleman G., Goldowitz D., Tokunage S., and Silvers J.M. Acute mild footshock alters ethanol drinking and plasma corticosterone levels in C57BL/6J male mice, but not DAB2/J or A/J male mice. Alcohol 42 (2008) 469-476
33. McClearn G.E., and Rodgers D.A. Differences in alcohol preference among inbred strains of mice. Quart. J. Stud. Alcohol 20 (1959) 691
34. Miczek K.A., and de Almeida R.M. Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline. Psychopharmacology (Berl.) 157 (2001) 421-429
35. Mikkelsen J.D., Soderman A., Kiss A., and Mirza N. Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis. Eur. J. Pharmacol. 519 (2005) 223-230
36. Myers E.A., Banihashemi L., and Rinaman L. The anxiogenic drug yohimbine activates central viscerosensory circuits in rats. J. Comp. Neurol. 492 (2005) 426-441
37. Nishii H., Nomura M., Aono H., Fujimoto N., and Matsumoto T. Up-regulation of galanin and corticotropin-releasing hormone mRNAs in the key hypothalamic and amygdaloid nuclei in a mouse model of visceral pain. Regul. Pept. 141 (2007) 105-112
38. Nomura M., Serino R., Yamamoto Y., Ozaki Y., Saito J., Matsumoto T., Yamashita H., and Ueta Y. Upregulation of CRH gene expression and downregulation of arginine vasopressin gene expression in the hypothalamus of bilateral nephrectomized rats. Life Sci. 72 (2002) 501-509
39. Paxinos G., and Franklin K. The Mouse Brain in Stereotaxic Coordinates (2004), Elsevier Academic Press, Amsterdam
40. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24 (1986) 525-529
41. Pellow S., and File S.E. The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response. Physiol. Behav. 35 (1985) 587-590
42. Rodgers R.J., Cole J.C., Aboualfa K., and Stephenson L.H. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. 52 (1995) 805-813
43. Sahun I., Gallego X., Gratacos M., Murtra P., Trullas R., Maldonado R., Estivill X., and Dierssen M. Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry. Amino Acids 33 (2007) 677-688
44. Stephens D.N., Schneider H.H., Kehr W., Jensen L.H., Petersen E., and Honore T. Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacy. Brain Res. Bull. 19 (1987) 309-318
45. Stone E.A., Quartermain D., Lin Y., and Lehmann M.L. Central alpha1-adrenergic system in behavioral activity and depression. Biochem. Pharmacol. 73 (2007) 1063-1075
46. Swanson L.W., Sawchenko P., Rivier J., and Vale W. Organization of bovine corticotropin releasing factor immunoreactive cells and fibers in the rat brain. Neuroendocrinology 36 (1983) 165
47. Trinh J.V., Nehrenberg D.L., Jacobsen J.P., Caron M.G., and Wetsel W.C. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience 118 (2003) 297-310
48. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
49. Wang L. The Role of Stress in Relapse to Alcohol (2002), University of Toronto
50. Yoneyama N., Crabbe J.C., Ford M.M., Murillo A., and Finn D.A. Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42 (2008) 149-160